Mastodawn

I can't tell if I'm nauseous because I'm hungry or if I'm nauseous because I'm in pain.

Pizza will help me solve this problem.
#pizza #wegovy #ouchies

Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage

Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.

https://www.cnbc.com/2026/06/08/novo-nordisk-eli-lilly-obesity-pills-medicare-coverage.html

#TopNews #News #Lilly #Novo #Wegovy

Ny Teknik 2d ago

JUST NU: Jätteframgång i USA för danskt bantningspiller – säljer rekordsnabbt#novonordisk #usa #wegovy #tt #samhälle #ozempic
Jätteframgång i USA för danskt bantningspiller – säljer rekordsnabbt

Jätteframgång i USA för danskt bantningspiller – säljer rekordsnabbt

Fem månader efter lanseringen i USA har bantningspillret Wegovy redan skrivits ut till över tre miljoner personer i landet.

nyteknik

xakan, parfois 5d ago

Il est ce moment de la semaine, avec une perte de 2,5kg cette semaine. Changement de dizaine.
#Obésité #Wegovy

Howard Smith MD, AM 6d ago

Why Those Taking Weight Loss Pills Stop Losing Weight. The reason is in your brain cells. References on my website. #Ozempic #Wegovy #WeightLossResearch #GLP1 #HealthyAging
https://www.instagram.com/p/DZLLmxzpLFP/

Howard G. Smith MD, AM on Instagram: "Why Those Taking Weight Loss Pills Stop Losing Weight You’re getting those weight loss shots. You’re delighted as you lose weight for months. Then those scale numbers suddenly stops moving in the right direction. Why? NIH endocrinologists now show that the answer appears to be hiding inside your brain cells. They find that semaglutide, the active ingredient in Ozempic and Wegovy, triggers variable responses in appetite-controlling brain cells. That seems to be why some people lose more weight than others and why weight loss often plateaus over time. Their studies of brain tissue in mice show that semaglutide boosts a signaling molecule called cAMP inside neurons that helps regulate your appetite. But not all brain cells respond the same way. Some maintain the signal for longer periods, while others appeared to shut down their responses more quickly. When they do, the appetite-suppressing effects weaken and contribute to the weight-loss plateau that many patients experience. This finding suggests a possible way to prolong the drug’s effects. By blocking an enzyme called PDE4 with a medication known as roflumilast, the investigators were able to extend the cAMP signal in more neurons. While this finding was observed only in mice and has not been confirmed in people, it raises the possibility that future treatments could help you continue losing weight and maintain that ideal weight for longer periods of time. The references for this report are available on my website. #Ozempic #Wegovy #WeightLossResearch #GLP1 #HealthyAging"

0 likes, 0 comments - drhowardsmithreports on June 4, 2026: "Why Those Taking Weight Loss Pills Stop Losing Weight You’re getting those weight loss shots. You’re delighted as you lose weight for months. Then those scale numbers suddenly stops moving in the right direction. Why? NIH endocrinologists now show that the answer appears to be hiding inside your brain cells. They find that semaglutide, the active ingredient in Ozempic and Wegovy, triggers variable responses in appetite-controlling brain cells. That seems to be why some people lose more weight than others and why weight loss often plateaus over time. Their studies of brain tissue in mice show that semaglutide boosts a signaling molecule called cAMP inside neurons that helps regulate your appetite. But not all brain cells respond the same way. Some maintain the signal for longer periods, while others appeared to shut down their responses more quickly. When they do, the appetite-suppressing effects weaken and contribute to the weight-loss plateau that many patients experience. This finding suggests a possible way to prolong the drug’s effects. By blocking an enzyme called PDE4 with a medication known as roflumilast, the investigators were able to extend the cAMP signal in more neurons. While this finding was observed only in mice and has not been confirmed in people, it raises the possibility that future treatments could help you continue losing weight and maintain that ideal weight for longer periods of time. The references for this report are available on my website. #Ozempic #Wegovy #WeightLossResearch #GLP1 #HealthyAging".

Instagram

Trekker21 Jun 3

The exhilaration I get from a walk like this is undeniable.

#BeInspired #GettingFitInMy50s #Walking #HealthJourney #232bGoal #Wegovy

Show thread

Dave J Jun 2

#Wegovy’s approval hangs on formulating strict health criteria to limit expenditure whilst still addressing #PublicHealth needs.

Until then, it’s largely patients who can afford $250-300/month out-of-pocket who enjoy its numerous #health benefits, a cohort that can generally afford healthier #nutrition and lifestyle practices anyway.

Once again, it seems, the best health advice is: “Don’t be poor.” 🤬 (2/2)

Dave J Jun 2

#Ozempic’s partially subsided by the #PharmaceuticalBenefitsScheme for blood glucose management and pre-surgery weight loss. #Wegovy—the same drug, #semaglutide, sold under a different name to treat #obesity and other conditions—currently isn’t, though it’s looking positive.

~65% of #Australia’s population could benefit from GLP-1 agonists, but the #PBS can’t possibly meet eligible demand. (1/2)

Re: https://social.chinwag.org/@abc_bot/116682082466028205 #auspol #health #medicine #diabetes #poverty

Unofficial ABC News Bot (@[email protected])

Ozempic-like drugs may improve kidney disease outcomes: study https://www.abc.net.au/news/health/2026-06-03/ozempic-style-drugs-improve-kidney-disease-outcomes-study/106743854 #LiverandKidneys #Pharmaceuticals #MedicalResearch #HeartDisease #Health

Chinwag Social